Clinical trial
The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics
NCT00068094 · National Center for Complementary and Integrative Health (NCCIH), NIH · Terminated
Key facts
| NCT number | NCT00068094 |
|---|---|
| Title | The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics |
| Official title | The Effect of a Probiotic on Hepatic Steatosis |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Fatty Liver, Hepatic Steatosis, Diabetes Mellitus, Liver Diseases |
| Intervention type | Drug |
| Interventions | Probiotic-containing powder |
| Enrollment | 30 |
| Start date | Jul 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Sep 9, 2003 |
| Last update posted | Aug 18, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: